Usted buscó: behandlingsgrupperna (Sueco - Inglés)

båda behandlingsgrupperna fick multivitamintillskott.
both populations received multivitamin supplements.

10 behandlingsgrupperna kunde visas.
3.4% for botox in the pooled sample and 10% for xeomin vs.

ör jämförbara i de båda behandlingsgrupperna.
ed type 2 diabetes

(≥ 2% skillnad mellan behandlingsgrupperna i
nci-ctc grade 3-5 reactions (≥ 2% difference between the study arms in at

medianbehandlingstiden var 15 dagar i båda behandlingsgrupperna.
the median treatment duration was 15 days in both treatment arms.

behandlingsgrupperna i minst en klinisk studie)
between the study arms in at least one clinical trial)

tabell 4 aer (µg/ min) i behandlingsgrupperna
table 4

händelsefrekvensen sjunker med ökande crcl i båda behandlingsgrupperna.
there is a decreasing event rate at increasing crcl in both treatment groups.

djuren fördelas slumpvis i kontroll- och behandlingsgrupperna.
animals should be randomly assigned to the control and treatment groups.

förekomsten av symtomatisk dvt var jämförbar mellan behandlingsgrupperna:
the incidence of symptomatic dvt was similar between treatment groups:

ingen märkbar skillnad i biverkningsfrekvens sågs mellan behandlingsgrupperna.
no notable differences in the frequency of adverse drug reactions were seen between treatment groups.

det fanns inga andra skillnader i säkerhetsprofil mellan behandlingsgrupperna.
there were no other differences in safety profile between the treatment arms.

hematologiska maligniteter förekom lika ofta i båda behandlingsgrupperna (1,6 %).
the rate of haematologic malignancies were the same between the two treatment arms (1.6%).

nt symptomatisk vte, inkluderande le, sågs ingen signifikant skillnad mellan behandlingsgrupperna.
the incidence of symptomatic vte, including pe was not significantly different between treatment groups.

# med en högre incidens (skillnad > 2% mellan behandlingsgrupperna).
#with a higher incidence (difference of ≥ 2% between the treatment arms).

beträffande incidensen symptomatisk vte, inkluderande le, sågs ingen signifikant skillnad mellan behandlingsgrupperna.
the incidence of symptomatic vte, including pe was not significantly different between treatment groups.

dag 0 - behandlingsgrupp
day 0-treated group